Home
FaceHeart

FaceHeart

Taiwanese AI biosensing company whose FH Vitals SDK is an FDA-cleared Class II medical software that performs contactless rPPG-based vital-signs measurement, including blood pressure estimation, through a standard smartphone or webcam camera.

Revenue

$0 M

Revenue Growth YoY

Users

Team & Hiring

Employees

~35

Open Roles

Unlock full report

Get the complete competitive intelligence dashboard with strategy analysis and weekly briefings.

Positioning

FDA-cleared contactless video-based vital signs measurement software powered by cutting-edge AI image recognition technology.

Apr 26 – Jun 26

Check Your Vital Signs via a 50-second “Facial Scan”

Jun 26 – Jun 26

05/2606/26

FDA-cleared contactless video-based vital signs measurement software powered by cutting-edge AI image recognition technology.

Check Your Vital Signs via a 50-second “Facial Scan”

FaceHeart

Homepage

11 page changes detected

changed claim: 'FDA-cleared contactless video-based vital signs measurement software powered by cutting-edge AI image recognition technology.' -> 'Check Your Vital Signs via a 50-second “Facial Scan”'⁠

new promo section: FDA clearance claim and two 510(k) clearances 'The First FDA-Cleared Contactless Video-Based Vital Sign Solution'⁠

new promo section: 'Why FaceHeart' benefits with FDA 510(k) clearances and contactless SDK⁠

new section: Health metrics list with rPPG vitals (12 items)⁠

new section: Applications & Use Cases with use-case tabs and value proposition⁠

replaced footer: added 'FDA-cleared contactless vital signs monitoring technology', new product and solutions links, removed phone/address/email⁠

new section: '3 Steps to Your Health Check' explains 3-step facial scan flow⁠

new faq: multiple Q&As about FaceHeart Vitals features and FDA clearances⁠

new promo section: 'Contactless Vital Sign Monitoring' CTA and contact link⁠

changed news section: detailed news list removed, only 'News' badge remains⁠

changed section headline: 'Partnership' -> 'Trusted by Industry Leaders'⁠

FaceHeart

News

FaceHeart CardioMirror FDA Class II Clearance

FaceHeart unveils CardioMirror, a non-contact AI device that detects atrial fibrillation and heart failure risk via a 50-second facial analysis. On-device AI monitors heart rate, respiration, and blood pressure across clinics, gyms, pharmacies, and homes, achieving 84.62% predictive accuracy.

taiwan-healthcare.org

FaceHeart

News

FaceHeart Unveils CardioMirror

FaceHeart launches CardioMirror, a health mirror using facial analysis to detect atrial fibrillation and heart failure risk in 50-second sessions. It monitors heart rate, respiration, and blood pressure across three models, with FDA Class II clearance and 84.62% accuracy.

taiwan-healthcare.org

FaceHeart

News

FaceHeart CardioMirror FDA Class II Clearance

taiwan-healthcare.org

FaceHeart

News

FaceHeart Unveils Privacy-Preserving Biosensing AI

FaceHeart released a video-based system that infers heart rate, blood pressure, fatigue, and emotional state without exposing facial features. The project, developed with MediaTek in its first year and led by Professor Wu Bing-fei, is valued at NT$500 million.

finance.technews.tw

FaceHeart

News

FaceHeart Earns FDA Substantial Equivalence

FaceHeart earns FDA substantial equivalence for its optical camera health software. Premarket device (Product Code QME, Regulation 870.2785) meets safety and effectiveness via a de novo or 510(k) pathway and is substantially equivalent to Mindset Medical, Nuralogix, OxeHealth, PanopticAI, Qompium.

accessdata.fda.gov

Unlock full activity feed

Real-time updates on website changes, news, social media posts, ads, and more.